8-K: VSee Health Receives Nasdaq Non-Compliance Notice for Late 10-Q Filing

VSee Health, Inc. has received a notice from Nasdaq regarding its non-compliance with listing rules due to the untimely filing of its Annual Report on Form 10-Q for the period ended March 31, 2025.

Summary

• VSee Health, Inc. (the "Company") received a notice from The Nasdaq Stock Market LLC on May 23, 2025, indicating non-compliance with Nasdaq Listing Rule 5250(c)(1).
• The non-compliance stems from the Company's failure to timely file its Annual Report on Form 10-Q for the period ended March 31, 2025, with the Securities and Exchange Commission (SEC).
• The notice has no immediate effect on the listing of the Company's Common Stock (Nasdaq: VSEE) or public warrants (Nasdaq: VSEEW).
• VSee Health has 60 calendar days from May 23, 2025, to submit a plan to regain compliance.
• If the compliance plan is accepted, Nasdaq may grant an exception of up to 180 calendar days from the Form 10-Q's due date, which would extend the compliance period until October 13, 2025.
• The Company intends to take the necessary steps to regain compliance as soon as practicable and expects to submit a plan and/or file the Form 10-Q within the initial 60-day period.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the formal notice of non-compliance from Nasdaq regarding a critical financial reporting obligation. While there's no immediate delisting, the situation introduces significant uncertainty and risk regarding the Company's continued listing and operational efficiency. The company's stated intent to comply offers a slight positive, but the 'no assurance' clauses weigh heavily.

Positives

• The notice of non-compliance has no immediate effect on the listing of VSee Health's Common Stock or public warrants on Nasdaq.

Negatives

• VSee Health, Inc. is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the failure to timely file its Annual Report on Form 10-Q for the period ended March 31, 2025.
• There is no assurance that a plan of compliance will be submitted or the Form 10-Q filed within the 60-day period.
• There is no assurance that Nasdaq will grant an exception of up to 180 calendar days.
• There is no assurance that the Company will be able to meet the continued listing requirements during any compliance period that may be granted by Nasdaq.

Risks

• Risk of delisting from Nasdaq if the Company fails to regain compliance with listing rules.
• Uncertainty regarding the acceptance of the Company's compliance plan by Nasdaq.
• Uncertainty regarding the Company's ability to file the Form 10-Q or meet compliance standards within the stipulated periods.
• Potential negative impact on investor confidence and stock price due to non-compliance and delisting risk.

Future Outlook

VSee Health intends to take the necessary steps to regain compliance with Nasdaq's listing rules as soon as practicable and currently expects to submit a plan of compliance and/or file the Form 10-Q within the 60-day period granted by Nasdaq. However, the Company explicitly states there can be no assurance that these actions will be completed or that compliance will be regained.

Management Comments

• "The Company intends to take the necessary steps to regain compliance with Nasdaq's listing rules as soon as practicable and currently expects to submit a plan of compliance with Nasdaq and/or file the Form 10-Q within the 60-day period granted by Nasdaq in the Notice."

Industry Context

This announcement highlights the ongoing regulatory scrutiny faced by publicly traded companies, particularly regarding timely and accurate financial reporting. Non-compliance with listing standards, while not uncommon, can signal operational or administrative challenges within a company, potentially impacting investor confidence. Companies in the telehealth sector, like VSee Health, are subject to the same stringent reporting requirements as other public entities, and maintaining good standing with exchanges like Nasdaq is crucial for market access and liquidity.

Stakeholder Impact

• Shareholders: Potential negative impact on share price due to delisting risk and uncertainty. Increased scrutiny on the company's ability to meet regulatory obligations.
• Regulatory Authorities: Nasdaq and SEC will monitor the Company's progress in regaining compliance.

Next Steps

• VSee Health must submit a plan to regain compliance with Nasdaq within 60 calendar days from May 23, 2025.
• VSee Health must file its Annual Report on Form 10-Q for the period ended March 31, 2025, with the SEC.
• If the plan is accepted, VSee Health must meet continued listing requirements during a potential 180-day exception period (until October 13, 2025).

Key Dates

Recommendation

Keywords

VSee Health, Nasdaq, Form 10-Q, SEC filing, listing compliance, delisting risk, financial reporting, VSEE, VSEEW, telehealth